Published Date: 02 Jun 2023
A recent study, which was published in the Proceedings of the National Academy of Sciences, demonstrates that eradicating breast and prostate cancer in animal models.
Read Full NewsVistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage trial testing its ability to reduce symptoms in...
Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.
1.
Early-Onset Colorectal Cancer in Male Veterans is Predicted by Risk Factors.
2.
Global inequalities found in cancer research funding
3.
Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.
4.
Drop in credit score after cancer diagnosis linked to increased mortality
5.
For treatment, the majority of cancer patients choose complementary therapies.
1.
Case Study: Genomic Medicine in Precision Oncology
2.
Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management
5.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
3.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
5.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation